Thiamine supplementation to cancer patients: A double edged sword

Anticancer Research

Volumn 18, Issue 1 B, 1998, Pages 595-602

  Boros, Laszlo G ^a   Brandes, James L ^a   Lee, Wai Nang Paul ^b   Cascante, Marta ^c   Puigjaner, Joaquim ^c   Revesz, Eva ^d   Bray, Tammy M ^d   Schirmer, William J ^a   Melvin, W Scott ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemotherapy resistance; Pentose phosphate pathways; Ribose synthesis; Transketolase reaction; Vitamin B1

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; ENZYME INHIBITOR; METHOTREXATE; NUCLEIC ACID; OXYTHIAMINE; RIBOSE; THIAMINE; TRANSKETOLASE;

ARTICLE; CANCER; CANCER PATIENT; DIET SUPPLEMENTATION; HUMAN; NUCLEIC ACID SYNTHESIS; ORAL DRUG ADMINISTRATION; PANCREAS CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; VITAMIN INTAKE;

ANTINEOPLASTIC AGENTS; CELL DIVISION; GUIDELINES; HUMANS; NEOPLASMS; NUCLEIC ACIDS; THIAMINE; TRANSKETOLASE;

EID: 0031900422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Seear M, Lockitch G, Jacobson B, Quigley G, MacNab A: Thiamine, riboflavin, and pyridoxine deficiencies in a population of critically ill children. Journal of Pediatrics 121: 533-538, 1992.
2. Henquin N, Havivi J, Reshef A, Barak F, Hom Y: Nutritional monitoring and counselling for cancer patients during chemotherapy. Oncology 46: 173-177, 1989.
3. Lossos A, Siegal T: Electric shock-like sensations in 42 cancer patients: clinical - characteristics and distinct etiologies. Journal of Neuro-Oncology 29: 175-181, 1996.
4. Yeh KH, Cheng AL: Acute confusion induced by a high-dose infusion of 5- fluorouracil and folinic acid. Journal of the Formosan Medical Association 93: 721-723, 1994.
5. De Reuck JL, Sieben GJ, Sieben-Praet MR, Ngendahayo P, De Coster WJ, Vander Eecken HM: Wernicke's encephalopathy in patients with tumors of the lymphoid- hemopoietic systems. Archives of Neurology 37: 338-341, 1980.
6. Bruck W, Christen HJ, Lakomek H, Hanefeld F, Friede RL: Wernicke's encephalopathy in a child with acute lymphoblastic leukemia treated with polychemotherapy. Clinical Neuropathology 10: 134-136, 1991.
7. Kalmanchey R, Magyarossi E, Majtenyi K, Koos R: Wernicke's encephalopathy in childhood osteosarcoma. Review. Orvosi Hetilap 133: 2503-2505, 1992.
8. Rouzet P, Rubie H, Robert A, Dutour A, Olives JP, Scipioni C, GuitardJ, Regnier C: Severe hyperlactacidemia in 2 children treated for malignant tumors. Role of vitamin B1. Archives Francaises de Pediatrie 48: 423-426, 1991.
9. Kondo K, Fujiwara M, Murase M, Kodera Y, Akiyama S, Ito K, Takagi H: Severe acute metabolic acidosis and Wernicke's encephalopathy following chemotherapy with 5-fluorouracil and cisplatin: case report and review of the literature. Japanese Journal of Clinical Oncology 26: 234-236, 1996.
10. Kitamura K, Yamaguchi T, Tanaka H, Hashimoto S, Yang M, Takahashi T: TPN- induced fulminant beriberi: a report on our experience and a review of the literature. Surgery Today 26: 769-776, 1996.
11. 1). In: Mahan KL, Arlin M, eds. Food, Nutrition and Diet Therapy, 8th ed. Philadelphia, PA: W. B. Sauoders Company; pp: 85-87, 1992.
12. Boros LG, Puigjaner P, Cascante M, Lee WP, Brandes JL, Bassilian S, Yusuf FI, Williams RD, Muscarella P, Melvin WS, Schirmer WJ: Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative sytnhesis of ribose and tumor cell proliferation. Cancer Research 57: 4242-4249, 1997.
13. Brennan MF: Supportive care of the cancer patient: Nutritional support. In: DeVita, Hellman and Rosemberg, eds. Cancer, Principles & Practice of Oncology, 2nd ed, Philadelphia, PA: JB Lippincott Company; pp: 1907-1912, 1985.
14. Trebukhina RV, Kravchuk RI, Mikhaltsevich GN, Petushok VG, Nikitin VS: Effect of thiamine and its antimetabolite oxythiamine on the proliferative activity of carcinosarcoma Walker 256 cells. Eksperimentalnaia Onkologiia 9: 60-63, 1987.
15. Baker H, Frank O, Chen T, Feingold S, DeAngelis B, Baker ER: Elevated vitamin levels in colon adenocarcinoma as compared with metastatic liver adenocarcinoma from colon primary and normal adjacent tissue. Cancer 47: 2883-2886,1981.
16. Basu TK, Dickerson JW: The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. Oncology 33: 250-252, 1976.
17. Souba WW: Clinical manifestations of cancer cachexia: Nutritional support. In: DeVita, Hellman and Rosemberg, eds. Cancer, Principles and Practice of Oncology, 5th ed, Philadelphia, PA: JB Lippincott Company; pp: 2841-2855, 1997.
18. Horecker BL, Domagk G, Hiatt HH: A comparison of C14-labeling patterns in deoxyribose and ribose in mammalian cells. Archives of Biochemistry and Biophysics 78: 510-517, 1958.
19. Georgiannos SN, Weston PM, Goode AW: Micronutrients in gastrointestinal cancer. British Journal of Cancer 68: 1195-1198, 1993.
20. 14C]thiamin and activities of thiamin pyrophosphate-dependent enzymes in tissues of mice with Ehrlich 's ascites carcinoma. Nutrition and Cancer 6: 260-273, 1984.
21. Trebukhina RV, Ostrovsky YuM, Shapot VS, Petushok VG, Velichko MG, Tumanov VN, Mikhaltsevich GN: Thiamine metabolism in the liver of mice with Ehrlich 's ascites carcinoma. Neoplasma 29: 257-268, 1982.
22. Ostrovskii IuM, Trebukhina RV, Mikhaltsevich GN: Tumor and body inter- relationships in C-thiamine utilization. Biulleten Eksperimentalnoi Biologii i Meditsiny 88: 708-710, 1979.
23. Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T: Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates. Cancer Research 48: 3330-3335, 1988.
24. Naujokaitis SA: Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system. Research Communications in Chemical Pathology and Pharmacology 32: 317-327, 1981.
25. 1 and PP and their use in oncological practice. Voprosy Meditsinskoi Khimii 38: 33-36, 1992.
26. Pekovich SR, Martin PR, Singleton CK: Thiaminepyrophosphate-requiring enzymes are altered during pyrithiamine-induced thiamine deficiency in cultured human lymphoblasts. Journal of Nutrition 126: 1791-1798, 1996.
27. Khokha AM, Fustochenko BP, Nefedov LI: Synthesis of nucleic RNA in hydroxythiamine-induced vitamin B 1 deficiency. Biokhimiia 49: 1166-1170, 1984.
28. Khokha AM, Fustochenko BP, Ostrovskii IuM: Peculiarities of nucleotide and nucleic acid metabolism in hydroxythiamine-induced vitamin B deficiency. Biokhimiia 49: 361 -369, 1984.
29. Gorbach ZV, Ostrovskii IuM: Possible mechanism of action of oxythiamine on nucleic acid metabolism. Biokhimiia 42: 531-533, 1977.
30. Stryer L: Pyruvate Dehydrogenase Complex; The α-Ketoglutarate Dehydrogenase Complex. In: Stryer L, eds. Biochemistry. 2nd ed. San Francisco, CA: WH Freeman Company; pp: 290-294, 1981.
31. Champe PC, Harvey RA. Hexose monophosphate pathway: Nonoxidative reactions. In: Champe PC, Harvey RA, eds. Illustrated Reviews, Biochemistry. 2nd ed. Philadelphia, PA: JB Lippincott Company; pp: 110-113, 1994.
32. Horecker BL: Pathways of carbohydrate metabolism and their physiological significance. Journal of Chemical Education 42: 244-253, 1965.
33. Mycek MJ, Harvey RA, Champe PC: Anticancer drugs. Antimetabolites; Alkylating agents. In: Mycek MJ, Harvey RA, Champe PC, eds. mustrated Reviews, Pharmacology. 2nd ed. Philadelphia, PA: Lippincott-Raven; pp: 378-390, 1997.
34. Kim YA, King MT, Teague WE, Rufo GA, Veech RL, Passonneau JV: Regulation of the purine salvage pathway in rat liver. American Journal of Physiology 262: E344-352, 1992.
35. Bettendorff L: A non-cofactor role of thiamine derivatives in excitable cells?. [Review] Archives of Physiology and Biochemistry 104: 745-51, 1996.
36. Becher H, Weber M, Lohr GW: Purine nucleotide synthesis in normal and leukemic blood cells. Klinische Wochenschrift 56: 275-83, 1978.
37. Ostrovskii KuM, Voskoboev AI, Gorenshtenin BI, Dosta GA: Molecular-kinetic parameters of thiamine enzymes and the mechanism of antivitamin action of hydroxythiamine in animal organisms. Biokhimiia 44: 1551-1557, 1979.
38. Stryer L: Pentose Phosphate pathways and Gluconeogenesis: TPP, The prostetic group of the transketolase, transfers activated aldehydes. In: Stryer L, eds. Biochemistry. 2nd ed. San Francisco, CA: W.H. Freeman Company; pp: 340-341, 1981.
39. Wood T, Fletcher S: The affinity chromatography of transketolase. Biochimica et BiophysicaActa 527: 249-55, 1978.
40. Ostrovskii IuM: Impermeability of the blood-brain barrier to hydroxythiamine. Voprosy Meditsinskoi Khimii 11: 95-97, 1965.
41. Pavlenia AK, Ostrovskii IuM, Larin FS: Phospholipids in the liver and brain of animals in acute oxythiamine-induced avitaminosis B1. Voprosy Meditsinskoi Khimii 29: 73-76, 1983.
42. Geng MY, Saito H, Katsuki H: The effects of thiamine and oxythiamine on the survival of cultured brain neurons. Japanese Journal of Pharmacology 68: 349-352, 1995.
43. Strumilo SA, Senkevich SB, Vinogradov W: Effect of oxythiamine on adrenal thiamine pyrophosphate-dependent enzyme activities. Biomedica Biochimica Acta 43: 159-163, 1984.
44. Harata N, Iwasaki Y: Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metabolic Brain Disease 10: 159-174, 1995.
45. Greenwood J, Pratt OE: Comparison of the effects of some thiamine analogues upon thiamine transport across the blood-brain barrier of the rat. Journal of Physiology 369: 79-91, 1985.
46. Boer P, Sperling O: Role of cellular ribose-5-phosphate content in the regulation of 5-phosphoribosyl-1-pyrophosphate and de novo purine synthesis in a human hepatoma cell line. Metabolism: Clinical and Experimental 44: 1469-1474, 1995.
47. Sagone AL, LoBuglio AF, Balcerzak SP: Alterations in Hexose Monophosphate Shunt During Lymphoblastic Transformation. Cellular Immunology 14: 443-452, 1974.
48. Banki K, Hutter E, Colombo E, Gonchoroff NJ, Perl A: Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. Journal of Biological Chemistry 271: 32994-3001, 1996.
49. Schrader MC, Eskey CJ, Simplaceanu V, Ho C: A carbon-13 nuclear magnetic resonance investigation of the metabolic fluxes associated with glucose metabolism in human erythrocytes. Biochim Biophys Acta 1182: 162-178, 1993.
50. Schiano TD, Klang MG, Quesada E, Scott F, Tao Y, Shike M: Thiamine status in patients receiving long-term home parenteral nutrition. American Journal of Gastroenterology 91: 2555-9, 1996.
51. Elsborg L, Nielsen JA, Bertram U, Helms P, Nielsen K, Rosenquist A: The intake of vitamins and minerals by the elderly at home. International Journal for Vitamin and Nutrition Research 53: 321-9, 1983.
52. Bailar JC, Gomik HL: Cancer undefeated. New England Journal of Medicine 336: 1569-74, 1997.
53. Doiron B, Cuif MH, Chen R, Kahn A; Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. Journal of Biological Chemistry 271: 5321-4, 1996.
54. Nishimura M, Uyeda K: Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6- phosphate, 2-kinase: fructose-2,6-bisphosphatase. Journal of Biological Chemistry 270: 26341-6, 1995.